CircPlekha7 suppresses renal fibrosis via targeting miR-493-3p/KLF4. Supplementary figure

Figure S1. Overexpression of circPlekha7 suppressed EMT and fibrosis of primary TECs. (A) Relative circPlekha7 levels in TECs transfected with pcDNA3.1-circPlekha7-mini or pcDNA3.1-mini. (B) Relative circPlekha7 levels in transfected TECs with TGF-β1 treatment (10 ng/mL). (C) Western blotting to measure levels of fibrosis- and EMT-related proteins in transfected TECs with TGF-β1 treatment. (D) Transwell assay to examine the migration ability of transfected TECs with TGF-β1 treatment. *P < 0.05, **P < 0.01, ***P < 0.001.